Neoadjuvant therapy in localized non-small cell lung cancer: can we do better than chemotherapy?
Author(s) -
Brittney Chau,
Ashwin Shinde,
Arya Amini
Publication year - 2019
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2019.08.43
Subject(s) - gefitinib , erlotinib , medicine , oncology , epidermal growth factor receptor , lung cancer , chemotherapy , tyrosine kinase , tyrosine kinase inhibitor , targeted therapy , cancer , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom